Brevan Howard Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 40,091 shares of RXRX stock, worth $435,789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,091Holding current value
$435,789% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
338Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$370 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$352 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$270 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$188 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$159 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.96B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...